Illumina plans population-scale microarray test; Venter downplays likelihood of HLI contributing to the Precision Medicine Initiative;

> Illumina ($ILMN) shared details of its plans to gather data to support the creation of a population-scale microarray test. Article

> J. Craig Venter dismissed the proposition of Human Longevity, Inc. sharing data with the Precision Medicine Initiative as "unlikely." Piece

> OmniComm signed up a CRO for a 5-year deal covering its TrialMaster electronic data capture system. Release

> Genomics England added Australia's Garvan Institute of Medical Research to its list of collaborators. News

> Balaji Venkateswaran joined DNAnexus as chief technology officer. Item

> Eastern European drug discovery firm Selvita set up a bioinformatics-focused subsidiary. More

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.